Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40013042
Localisation
Japan
Asia
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
08/01/2026
Statut
Classification
1.5°C
Année cible
FY2030
Statut
Targets set
Classification
1.5°C
Année cible
FY2050
Overall Net-Zero Target: DAIICHI SANKYO CO.,LTD. commits to reach net-zero greenhouse gas emissions across the value chain by FY2050. Near-Term Targets: DAIICHI SANKYO CO.,LTD. commits to reduce absolute scope 1 and 2 GHG emissions 63% by FY2030 from a FY2015 base year. DAIICHI SANKYO CO.,LTD. Also commits to increase active annual sourcing of renewable electricity from 4.73% in FY2015 to 100% by FY2030. DAIICHI SANKYO CO.,LTD. further commits that 70.6% of its suppliers by emissions covering purchased goods and services, capital goods and upstream transportation and distribution, will have science-based targets by FY2030. Long-Term Targets: DAIICHI SANKYO CO.,LTD. commits to reduce absolute scope 1 and 2 GHG emissions 90.00% by FY2040 from a FY2015 base year. DAIICHI SANKYO CO.,LTD. commits to reduce absolute scope 3 GHG emissions 90.00% by FY2050 from a FY2020 base year.
Statut
Targets setAnnée cible
FY2050
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
ISIN
JP3475350009
LEI
353800XGIU2IHQGC9504
Source : Science Based Targets initiative | Données publiques